about
Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer.Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?Morphologic change of rectosigmoid colon using belly board and distended bladder protocolDo Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after MastectomyTrends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society ReportFeasibility and outcomes of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy for malignant gliomas: a preliminary report.The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiationPatterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy.Radiation-related heart disease after breast cancer radiation therapy in Korean women.Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea.Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancerImpact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer.Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancerImpact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy.Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma.Preoperative chemoradiotherapy effects on anastomotic leakage after rectal cancer resection: a propensity score matching analysis.Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume.Reconstruction using a perforator free flap after malignant melanoma resection of the ankle and foot.Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients.Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective.Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy.Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume.Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancerIncorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal CancerDefining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineationClinical Evaluation of Commercial Atlas-Based Auto-Segmentation in the Head and Neck RegionInfluence of Radiation Dose to Reconstructed Breast Following Mastectomy on Complication in Breast Cancer Patients Undergoing Two-Stage Prosthetic Breast Reconstruction
P50
Q28552864-AFA268DE-352B-4AE7-855A-6482EFFEF552Q33421574-09E85F02-50DB-4F2F-84EA-46FC91817107Q34255467-7272C8A9-872F-4848-B4F0-F995735FD8E2Q35651188-C9432A1B-13CF-4B5B-B6F9-A175D8A75D2BQ35824242-8D60401E-2C31-4DF4-AF88-3F7FF717BC0DQ36194009-A1764AC2-8039-4DB2-89C2-CE889BD758F1Q36292688-AE28FF25-202D-4D94-B482-ECB96A5509AFQ36786775-7009C79F-C37E-4F0C-8D71-5B3BE60C1F57Q36832255-CCC827DC-F120-41C6-B51A-DE98BEC9EA0AQ36993433-B2AFBF06-FE7A-45C2-BE8D-1ECABF873E85Q37418864-76B20BAB-C741-4727-AAE1-DF767C00D636Q37549514-9D0A5C40-1041-42D1-A300-15E1C1C6EDC3Q38043755-30E2F9B3-9BB9-4BC7-A083-AE3D2BB7D062Q38674514-8567C9E7-21B5-46E0-BBBD-20A94D7FAFC1Q38803935-45B36DFE-D501-4C75-9BBF-F12E35349A77Q38917073-1353A3A4-6021-4D07-B404-828D6984DEBFQ39103454-60C3C3F8-8DED-4A6D-9AA2-F93816AF3658Q39543776-C56B080F-D669-421E-953A-E5DB86EAE8D8Q39659101-98302B7A-D806-4517-8A5E-88DB8C3939C0Q40011137-D58AAE14-D5A8-462F-B8AB-540EA06556C8Q40706674-A4343BD8-EF1A-4B45-B611-65B8E7623CBFQ41848565-3EF5B961-B2FA-4F79-9B84-DBF0B59743D8Q42323296-8333A075-4DBE-433F-AAC9-885E849A106DQ43897398-8B77CD91-A52A-468C-9482-F59D39C5F377Q44076340-70CC1DAA-C2DF-4BA0-9685-3F11F5896FAFQ44853893-F96D20C3-81BB-4BC4-B5F8-70DDEA6A0E06Q47757766-1D1A0A2A-B49C-48E1-A8D7-0751DD6D2AC1Q47986286-F8BE2CEA-646A-4C8C-854A-F45194A24D07Q49194588-878BC461-79A1-42A5-982C-831911EECE8DQ49213845-01C9C77C-F0A8-486D-AE01-86BAEACCF192Q50118494-604BFFA4-C284-461F-9868-77C1A6067AE0Q50158378-D20C9EB6-EDD0-4322-9117-30FB6F157E41Q51101577-89508016-8B08-4F51-BC40-EB8EA331CEEDQ52983742-B5C59A74-1426-4E6E-B044-129FE69F8912Q53060142-2E2BAAE0-F65C-46C4-B488-95B373A3890CQ57222573-CBFC9932-D458-45CF-8B8D-7377ADE7F02BQ59115805-741AB242-E7A8-4E2F-87E5-B047EFF09BF3Q59115813-70990DFF-00C2-4247-8CF3-BE8AE19A2FA7Q64063393-81B8EE89-509B-4BB9-919B-08EEF639FCB2Q64063435-EFA246E0-C831-490C-A669-B4EC55F3BAB3
P50
description
researcher ORCID ID = 0000-0001-7685-3382
@en
wetenschapper
@nl
name
Jee Suk Chang
@ast
Jee Suk Chang
@en
Jee Suk Chang
@es
Jee Suk Chang
@nl
type
label
Jee Suk Chang
@ast
Jee Suk Chang
@en
Jee Suk Chang
@es
Jee Suk Chang
@nl
prefLabel
Jee Suk Chang
@ast
Jee Suk Chang
@en
Jee Suk Chang
@es
Jee Suk Chang
@nl
P106
P31
P496
0000-0001-7685-3382